Balaxi Pharmaceuticals

quarterly
yearly
ParticularsJun '21Sep '21Dec '21Mar '22Jun '22
Revenue58.3470.2361.7289.1082.78
Expenses47.0156.3248.3278.0469.22
EBITDA11.3313.9113.4011.0613.56
EBIT11.2613.7913.2410.8913.37
Profit Before Tax12.4914.0312.9815.0216.65
Net Profit10.7112.0512.1812.7114.15
Financial Ratios
Operating Profit Margin19.40%19.81%21.71%12.41%16.38%
Net Profit Margin18.36%17.16%19.73%14.26%17.09%
Earning Per Share (Diluted)10.7112.0512.1812.7114.15
Dividends Per ShareNANANA0.50NA
ⓒ 2016-2022 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.5.6
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI